Trial · NCT04581863
COVID-19 Watch + COVID-19 Pulse
NCT04581863, Not applicable, Completed, University of Pennsylvania; results first posted 2023-11-24
3 sourcestrials-2026-11-12-0.5.0
Download JSON
Cite this record
ConductScience Library. COVID-19 Watch + COVID-19 Pulse. Trials, record NCT04581863. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04581863
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- COVID-19 Watch + COVID-19 Pulse
- NCT number
- NCT04581863
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 2,097 participants, actual
- Lead sponsor
- University of Pennsylvania
- Conditions
- Covid19
- Interventions
- pulse oximeter, COVID Watch
- First posted
- 2020-10-09
- Last updated
- 2023-11-24
- Results first posted
- 2023-11-24
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Difference in Days Alive and Out of Hospital | 30 days | Primary outcome will be reported for patients who are confirmed to be COVID positive. Outcomes include time-based and categorical clinical outcomes. Time-based measures will be assessed at 30 days and begin when a COVID-19 patient was tested (e.g., nasopharyngeal swab) in outpatient and ED settings, or starting at the time of discharge from the hospital if enrolled in COVID Watch as an inpatient. Staying safe and out of the hospital using Days Alive and Out of Hospital (DAOH) since the date of the positive COVID-19 test. Initial analyses will include in-hospital deaths. Deaths that occur outside the hospital in 2020 will be added to a follow up analysis when National Death Index (NDI) becomes available (est. January 2021)." |
| Other | Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | 30 days | The mean number of days is per person. This data includes patients who presented to a health system hospital or any of 53 hospitals outside the health system captured in the regional health information exchange. |
| Other | Self-reported Anxiety Among COVID-19 Positive Patients | 0, 7, and 14 days | Patients were asked to rate their anxiety (1=very worried to 5=not at all worried) on Day 0, 7, and 14. |
| Other | Self-perception of Confidence in Managing Illness Among COVID-19 Positive Patients | 0, 7, and 14 days | Patients were asked to rate their confidence that they could manage their symptoms at home (1=not at all confident to 5=very confident) on Day 0, 7, and 14. |
| Other | Self-perception of Program Helpfulness in Managing Illness Among COVID-19 Positive Patients | 0, 7, and 14 days | Patients were asked to rate how helpful these found the program (1=not at all helpful to 5=very helpful) on Day 0, 7, and 14. |
| Other | Mortality Among COVID-19 Positive Patients | 30 days | The count of participants encompasses all deaths in each arm. This data includes patients who presented to a health system hospital or any of 53 hospitals outside the health system captured in the regional health information exchange. |
| Other | Mortality by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | 30 days | The count of participants encompasses all deaths with respect to each arm and each race/ethnic group. This data includes patients who presented to a health system hospital or any of 53 hospitals outside the health system captured in the regional health information exchange. |
| Other | Health Care Utilization (Outpatient, Emergency Department, and Inpatient Care) | 30 days | The mean number of visits/hospitalizations is per patient. Emergency and Hospitalizations include patients who presented to a health system hospital or any of 53 hospitals outside the health system captured in the regional health information exchange. Office visits are within the Penn health system and do not include patients who presented to any of 53 hospitals outside the Penn health system captured in the regional health information exchange. |
| Other | Health Care Utilization (Outpatient, Emergency Department, and Inpatient Care) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | 30 days | The mean number of visits/hospitalizations is per patient. This data includes patients who presented to a health system hospital or any of 53 hospitals outside the health system captured in the regional health information exchange. Office visits are within the Penn health system and do not include patients who presented to any of 53 hospitals outside the Penn health system captured in the regional health information exchange. |
| Other | Incidence of Remote Monitoring Escalations to Clinician | 30 days | Escalations to a clinician represents the number of unique patients who escalated to a clinician one or more times throughout enrollment per their allocated study. |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes16
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Difference in Days Alive and Out of Hospital | 30 days | days | MEAN | |
| OTHER_PRE_SPECIFIED | Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | 30 days | Days | MEAN | |
| OTHER_PRE_SPECIFIED | Self-reported Anxiety Among COVID-19 Positive Patients | 0, 7, and 14 days | score on a scale | MEAN | |
| OTHER_PRE_SPECIFIED | Self-perception of Confidence in Managing Illness Among COVID-19 Positive Patients | 0, 7, and 14 days | score on a scale | MEAN | |
| OTHER_PRE_SPECIFIED | Self-perception of Program Helpfulness in Managing Illness Among COVID-19 Positive Patients | 0, 7, and 14 days | score on a scale | MEAN | |
| OTHER_PRE_SPECIFIED | Mortality Among COVID-19 Positive Patients | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Mortality by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | 30 days | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Health Care Utilization (Outpatient, Emergency Department, and Inpatient Care) | 30 days | Number of Visits/Hospitalizations | MEAN | |
| OTHER_PRE_SPECIFIED | Health Care Utilization (Outpatient, Emergency Department, and Inpatient Care) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | 30 days | Number of Visits/Hospitalizations | MEAN | |
| OTHER_PRE_SPECIFIED | Incidence of Remote Monitoring Escalations to Clinician | 30 days | Participants | COUNT_OF_PARTICIPANTS |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 outcomesResults by group91
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Difference in Days Alive and Out of Hospital | COVID Watch | 29.5 | Standard Deviation 2.3 | days | |
| Difference in Days Alive and Out of Hospital | COVID Watch + Pulse Oximeter | 29.4 | Standard Deviation 2.8 | days | |
| Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | COVID Positive Black Patients - Control | 29.3 | Standard Deviation 2.6 | Days | |
| Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | COVID Positive Hispanic Patients - Control | 29.4 | Standard Deviation 1.5 | Days | |
| Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | COVID Positive White Patients - Control | 29.6 | Standard Deviation 2.4 | Days | |
| Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | COVID Positive Other/Unknown Patients - Control | 29.6 | Standard Deviation 1.5 | Days | |
| Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | COVID Positive Black Patients - Intervention | 29.5 | Standard Deviation .4 | Days | |
| Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | COVID Positive White Patients - Intervention | 29.3 | Standard Deviation 3.0 | Days | |
| Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | COVID Positive Hispanic Patients - Intervention | 29.1 | Standard Deviation 4.0 | Days | |
| Days Alive and Out of Hospital (DAOH) by Racial/Ethnic Subgroups Among COVID-19 Positive Patients | COVID Positive Other/Unknown Patients - Intervention | 29.3 | Standard Deviation 3.0 | Days |
1 to 10 of 91Source ClinicalTrials.gov
See all 91 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | COVID Watch | 1,041 | |
| Overall Study | STARTED | COVID Watch + Pulse Oximeter | 1,056 | |
| Overall Study | COMPLETED | COVID Watch | 1,024 | |
| Overall Study | COMPLETED | COVID Watch + Pulse Oximeter | 1,025 | |
| Overall Study | NOT COMPLETED | COVID Watch | 17 | |
| Overall Study | NOT COMPLETED | COVID Watch + Pulse Oximeter | 31 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | COVID Watch | 3 | 1,024 |
| Total, all-cause mortality | COVID Watch + Pulse Oximeter | 5 | 1,025 |
| Total, other adverse events | COVID Watch | 0 | 1,024 |
| Total, other adverse events | COVID Watch + Pulse Oximeter | 0 | 1,025 |
| Total, serious adverse events | COVID Watch | 0 | 1,024 |
| Total, serious adverse events | COVID Watch + Pulse Oximeter | 0 | 1,025 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons4
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| COVID Watch vs COVID Watch + Pulse Oximeter: Incidence of Remote Monitoring Escalations to Clinician | Trial comparisons |
| COVID Watch vs COVID Watch + Pulse Oximeter: Mortality Among COVID-19 Positive Patients | Trial comparisons |
| COVID Watch vs COVID Watch + Pulse Oximeter: deaths from any cause | Trial comparisons |
| COVID Watch vs COVID Watch + Pulse Oximeter: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04581863
GET https://conductscience.org/api/trials/v1/NCT04581863/results?page=2